Animated Video and Booklet Education for Improving Asthma Control and Medication Compliance in Children
The Effect of Animated Video and Booklet Education on Asthma Control and Medication Compliance in Children With Asthma: A Randomized Controlled Study
1 other identifier
interventional
66
1 country
1
Brief Summary
Asthma is a chronic inflammatory disease that causes wheezing, coughing, and shortness of breath, and it is a significant cause of morbidity and mortality in the pediatric population. The World Health Organization (WHO) estimated that 262 million people were affected by asthma in 2019, with 461,000 asthma-related deaths annually. In Turkey, the prevalence of asthma in children aged 6-12 ranges from 2% to 16%. Inadequate asthma control in children is often associated with poor medication adherence, lack of knowledge, misbeliefs, and ineffective communication with healthcare professionals. Education is therefore a crucial element of successful asthma management. Recently, the use of digital tools such as animated videos has become increasingly popular in pediatric education due to their engaging and interactive nature. Studies have shown that visual and interactive materials can improve knowledge, satisfaction, and adherence in children with chronic illnesses. This randomized controlled study aims to evaluate the effect of an educational intervention using an animated video and booklet on asthma control and medication compliance in children aged 7-11 diagnosed with asthma. It is expected that this child-friendly, visually enriched educational approach will enhance asthma management and support medication adherence in children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 27, 2025
CompletedFirst Posted
Study publicly available on registry
April 3, 2025
CompletedStudy Start
First participant enrolled
May 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2025
CompletedApril 8, 2025
March 1, 2025
4 months
March 27, 2025
April 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Asthma control score (Childhood Asthma Control Test - C-ACT)
Asthma control will be assessed using the Childhood Asthma Control Test (C-ACT), a 7-item validated scale for children aged 4-11. Scores range from 0 to 27. A score ≥20 indicates controlled asthma; ≤19 indicates uncontrolled asthma. It will be administered at baseline, 1st month, and 2nd month follow-up.
Baseline, 1st month, and 2nd month follow-up
Medication Adherence (MARS-5)
Medication adherence will be measured with the MARS-5 (Medication Adherence Report Scale), a 5-item Likert-type questionnaire. Scores range from 5 to 25; higher scores indicate better adherence. The scale will be administered at baseline, 1st month, and 2nd month.
Baseline, 1st month, and 2nd month follow-up
Study Arms (3)
Arm 1 - Animation Video Group
EXPERIMENTALChildren receive a 7-minute animated video titled "Living with Asthma" designed for ages 7-11, explaining asthma, its symptoms, triggers, and inhaler techniques through engaging characters. The video is watched initially during a clinic visit and then repeatedly at home with parental guidance over a two-month follow-up period. Parents record viewing frequency using the Parent Observation Form.
Arm 2 - Booklet Group
ACTIVE COMPARATORChildren receive a 12-page, illustrated asthma education booklet developed in accordance with GINA guidelines. The booklet is designed with child-friendly visuals and simple language. Parents are instructed to review the booklet with their children at least twice per week over two months and record reading activities using the Parent Observation Form.
Arm 3- Control Group
NO INTERVENTIONChildren receive routine care provided by the Pediatric Allergy and Immunology Outpatient Clinic. This includes standard written forms about allergen avoidance and treatment recommendations based on clinical assessments. No additional asthma education is given during the study period.
Interventions
This intervention consists of a 7-minute and 39-second animated video titled "Living with Asthma," specifically designed for children aged 7 to 11. The video features two characters, Mert and Robo, who explain asthma, its symptoms, triggers, and correct inhaler techniques in a child-friendly manner. The content is based on the latest GINA (2020) and NHLBI (2020) guidelines. The video is first watched in the clinic setting using a tablet device and then shared with parents via WhatsApp, email, or CD for home viewing. Parents are asked to watch the video with their child at least twice per week for two months and record viewing frequency using a structured observation form. This visual and engaging format distinguishes the intervention from conventional text-based education.
This intervention involves the distribution of a 12-page, full-color, illustrated educational booklet titled "Living with Asthma," developed for children aged 7 to 11. The booklet covers topics such as asthma symptoms, triggers, medication use, and device techniques using simple language and visual aids. Its content was developed in line with GINA (2020) and National Heart, Lung, and Blood Institute (2020) recommendations. During the initial clinic visit, children and parents are introduced to the booklet and instructed to review it together at least twice per week over two months. Parents are also asked to log reading sessions using a structured observation form. This printed, interactive material offers a visually supported, age-appropriate alternative to standard asthma education methods.
Eligibility Criteria
You may qualify if:
- Children aged between 7 and 11 years
- Diagnosed with asthma by a pediatric allergy specialist
- Mild or moderate asthma severity according to GINA criteria
- No communication difficulties
- Have not received any asthma-related education outside of routine clinical care during the study period
- No known mental or neurological disabilities
- No serious chronic illness other than asthma (e.g., cardiac, neurological conditions)
- At least one parent owns a smartphone or tablet
- Child and parent volunteer to participate and provide informed consent
You may not qualify if:
- Children younger than 7 or older than 11
- Severe persistent asthma according to GINA criteria
- Communication difficulties
- Prior asthma education outside of routine clinical care
- Children with cognitive or neurological impairments
- Children who frequently require emergency care due to asthma exacerbations
- Families without access to communication tools (e.g., no internet, smartphone, or unable to communicate)
- Lack of consent from either the child or parent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Trakya University Faculty of Health Sciences
Edirne, Turkey, 22050, Turkey (Türkiye)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Dr. Esra Nur Kocaaslan Mutlu, Assistant Professor of Pediatric Nursing, Trakya University
Study Record Dates
First Submitted
March 27, 2025
First Posted
April 3, 2025
Study Start
May 15, 2025
Primary Completion
September 15, 2025
Study Completion
October 15, 2025
Last Updated
April 8, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share